FDA Chief Defends Hydrocodone Painkiller Approval
The U.S. Food and Drug Administration adequately determined that the controversial new painkiller Zohydro ER offered benefits that outweigh its risks of abuse — a rampant problem with such prescription hydrocodone...To view the full article, register now.
Already a subscriber? Click here to view full article